Teradyne price target raised to $136 from $100 at Morgan Stanley

Morgan Stanley analyst Shane Brett raised the firm’s price target on Teradyne (TER) to $136 from $100 and keeps an Equal Weight rating on the shares. Teradyne’s core business of networking, memory, and Apple (AAPL) is strong, says the analyst, who revised up FY26-27 estimates to 8% and 3% above consensus, respectively. However, for further upside to the firm’s bull case target of $180, one needs to believe in the Nvidia (NVDA) optionality, the analyst tells investors.